Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) (“Beleave” or the “Company”) is pleased to be a sponsor and supporter of the Don’t Drive Hicampaign, a campaign aimed to reduce cannabis impaired driving.   With legislation for legalizing marijuana progressing, the year-long Don’t Drive Hicampaign is backed by prominent sponsors including advertising agency BBDO, radio stations Z103.5 and Energy 108, and safe driving advocates R.I.D.E. CHECKS and Arrive Alive DRIVE SOBER, all seriously committed to helping prevent driving under the influence of cannabis.
“Keeping our roads safe from tragedy is the focus of our Don’t Drive Hicampaign and we are particularly grateful to Beleave for lending their support to this important initiative,” said Lorne Simon, a leading safe driving advocate and founder of R.I.D.E. CHECKS. “Being backed by Beleave, a respected and forward-thinking company, is paramount to the success of the campaign and creating a culture where driving after consuming cannabis is never okay. Together we can spread awareness about being responsible and the devastating impact and consequences of driving drugged.”
Read more about the Don’t Drive Hi campaign here.
“It’s wonderful to see great communication, public education, and prevention initiatives like the Don’t Drive Hi campaign, that are committed to protecting Canadians by reducing the risks associated with cannabis impairment and driving,” commented Beleave CEO Dr. Roger Ferreira. “Beleave is proud to support the Don’t Drive Hi campaign in an effort to minimize the social costs and harms attributed to cannabis-related motor vehicle collisions in Canada.”
About Beleave
Beleave Inc. is a biotech company and Beleave’s wholly-owned subsidiary First Access Medical Inc. (“FAM”) is a licensed producer pursuant to the ACMPR. Beleave’s purpose-built facility is in Hamilton, Ontario.
Forward-Looking Statements
This news release contains forward-looking statements. The use of any of the words “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and similar expressions are intended to identify forward-looking statements. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. This news release includes forward-looking statements with respect to the completion of the ACMPR licensing process, meeting the requirements of the ACMPR, obtaining a license to cultivate pursuant to the ACMPR, and the start of production. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.

For more information contact:
Sebastian de Kloet
Phone: 1 (905) 979 – 5173
Email: Sebastian@beleave.com
www.beleave.com
Click here to connect with Beleave Inc. (CNSX:BE) to receive an Investor Presentation

Source: www.benzinga.com


Trulieve Cannabis Corp. (“Trulieve” or the “Company”) (CSE: TRUL) (OTCQX: TCNNF), a leading and top-performing cannabis company in the United States today announced the appointment of Marcum LLP (“Marcum”) as its independent registered public accounting firm, effective July 5, 2021 . Marcum was appointed following the resignation of MNP LLP (“MNP”) as the Company’s independent registered public accounting firm effective July 5, 2021 .

“We would like to thank MNP for their guidance and expertise over the past two years and we look forward to working with Marcum as the Company’s new independent registered public accounting firm,” stated Chief Financial Officer, Alex D’Amico.

Keep reading... Show less

Cannabis-infused beverages are not a new product concept, but this summer Canadian drink makers hope consumers will discover them for the first time.

Recreational cannabis beverages have beguiled Canadian producers through different avenues, and many continue to make investments. The promise of these drinks lies in the potential of a more welcoming option for new consumers who may be out of their depth with rolled-up dried flower.

Keep reading... Show less

In the news release, BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years, issued 07-Jul-2021 by BioHarvest Sciences Inc. over PR Newswire, we are advised by the company that an incorrect version of the release was issued inadvertently. The complete, corrected release follows:

BioHarvest Sciences Inc.‘s First Cannabis Cell Reservoir Produces Ongoing Flowering Stage Cannabinoid Cells For 2 Years

Keep reading... Show less

Trulieve is the first medical cannabis operator to start planting in the state

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today that it commenced operations in West Virginia . The Company has begun cultivation at their 100,000 square foot size facility in Huntington, West Virginia .

Keep reading... Show less

– The Company demonstrates the efficiency and reliability of its BioFarming technology by reducing production cycle time for Cannabis from 14-23 weeks to 3-4 weeks.

– The Company’s BioFarming technology will allow the Company to harvest 13-17 cycles per year versus 2-4 cycles per year for conventional Cannabis agriculture.

Keep reading... Show less